CXCL1 promotes immune escape in colorectal cancer by autophagy-mediated MHC-I degradation
CONCLUSION: CXCL1 promoted immune escape in CRC by autophagy-mediated MHC-I degradation, suggesting that CXCL1 may be a possible immunotherapeutic target for CRC.PMID:37802708 | DOI:10.1016/j.humimm.2023.09.002
Source: Human Immunology - Category: Allergy & Immunology Authors: Jianqiao Kong Song Xu Peng Zhang Yun Zhao Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Colorectal Cancer | Immunotherapy | Study